Confluence: https://teapaw.org/t.co/o1mu7JVJZi. Culture, technology, and business.
New York, NY
Joined July 2011
- Tweets2.5K
- Following28
- Followers72
- Likes20
Lessons in Bias for Machine Learning:
Algorithms are only as good as their human instructors
thirdstream.substack.com/p/l… #AI #MachineLearning
‘Do no harm’, attributed to the original Hippocratic Oath, is for physicians. If private equity firms had their own maxim for ethics it might look like this: ‘Insulate yourself from the consequences of your actions’. #healthcare #privateequity #LBO lnkd.in/e_CXV7YR
Lofty soul, inspired talent, and the greatest bricklayer in history. lnkd.in/eURYy2aQ #Florence #Architecture #Morricone
MIT economist @davidautor: "Recognizing this [AI's] potential, we should ask not what AI will do to us, but what we want it to do for us." nber.org/papers/w32140 #AI
Data centers are an essential part of the businesses for 40 leading operators and suppliers of digital infrastructure. Together, they represent more than one-third of the #Nasdaq-100's weighting. #datacenters #AI $AAOI $RXT thirdstream.substack.com/p/s…
Buying in anticipation of a short squeeze adds complicated tactical & speculative dimensions to what is already a challenging task. #shortselling #shortsqueeze $ALLO $BTAI $STEM lnkd.in/eJGM_GwA
Big VC-backed startups use predatory pricing to drive rivals out of the market; don't necessarily need to recoup their losses to succeed. Objective is to create perception of potential recoupment to entice investors. #venturecapital $UBER lnkd.in/ec_qNNxb
Top IPOs in 2022-23 were small-caps (all biotech) that raised sufficient capital to advance their pipelines over the next 24-36 months. Biggest IPO losers: overwhelmingly <$100M mc with barely enough cash to last until early '24. $GNLX $GPCR $APGE $SGMT lnkd.in/exhX4JmJ
For 1H 2023, 1,019 companies (avg. mc: $234M) in Third Stream Research's industry groups recorded an average gain of +12.0%. An emerging narrative indicates the gap between small growth and the market's leaders is primed to narrow. $ANAM $SGTX $INMN thirdstream.substack.com/p/e…
Amidst a dynamic deal landscape for #dermatologic companies, we explore if there are still compelling opportunities among smaller firms in this lucrative field. $SMTI thirdstream.substack.com/p/s…
Coincident with consumer sentiment’s rebound off a historical low level this year, performance data on cos in our universe (mktcap<$1B, covering TMT, Biotech, Health/LifeSci, Medtech & Cleantech) signals increasing bullishness for #emerginggrowth stocks. thirdstream.substack.com/p/m…
What consumer confidence and stock price trends tell us about mean regression for emerging growth companies. thirdstream.substack.com/p/m…
June 2023 Digest: Sizing Up Growth Stocks / eMagin This $EMAN / Watchlist Update $ORGS $PRPH / ‘Finfluencers’ vs. Pros. Despite surge in mega-techs and onset of S&P 500 bull market, our data on #emerginggrowth stocks indicate animal spirits remain tepid. thirdstream.substack.com/p/m…
Given the record of consolidation in the #3dprinting industry, investors should be skeptical about the latest round involving $SSYS, $DDD, $DM and $NNDM. thirdstream.substack.com/p/3…
Third Stream Research issues an Update Report on ProPhase Labs $PRPH with a Strong Buy recommendation for long-term market outperformance. #biotech #genomics thirdstream.substack.com/p/t…
Mechanization and automation allowed larger companies to take increased market share, according to a new study by Spencer Kwon from Harvard and his collaborators. #automation #megacap substack.com/inbox/post/1111…
David Booth, founder and chair of Dimensional Fund Advisors, asks ChatGPT: “Is it safer to trust the market price mechanism than rely on an AI model to find mispricing in stocks and bonds?” Answer: Don't trust AI over the wisdom of the crowd. #ai ft.com/content/074a273a-07fa…
Our monthly/quarterly/annual digests explore investment trends in the emerging growth universe, highlight the performance of the 1,000+ companies tracked by Third Stream Research, and focus on our expanding watch list. thirdstream.substack.com/p/m…
Of the 544 biotech cos tracked by Third Stream Research, 248 are down >50% over past year, 2/3 of which are currently nanocaps. Massive drawdown since mid-2021 was too indiscriminate. One prospect caught our attention amid the wreckage. $ORGS thirdstream.substack.com/p/p…